Fundraising FoxCongenica
Cambridge, GB · 12 known investors
Find your way into Congenica
Sign up to see every warm intro you have to Congenica
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Congenica team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories. The platform enables rapid identification and prioritization of clinically relevant genetic variants from sequencing data, with applications in cancer mutation detection, germline variant analysis, and pathogen identification.
Investors · 12
How we know: a partner's Signal profile · the Companies House PSC register · funding news · blog.congenica.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Future Planet Capital's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: QVentures's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Xeraya Capital's portfolio page · blog.congenica.com · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$50M disclosed across 1 of 3 rounds · 2019–2020
- $50MSeries CNov 2020 · 2 sources
Legal & General (lead), Tencent (lead), Cambridge Innovation Capital, Downing, IDO Investments, Parkwalk, Puhua Capital, Xeraya
Source ↗ - Undisclosed amountSeries BApr 2019Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Congenica went on to found or lead other companies.
Companies House · registry record
View on Companies House ↗- Registered name
- CONGENICA LTD
- Company number
- 08273616
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 30 Oct 2012
- Registered office
- Bic Wellcome Genome Campus, Hinxton, Cambridge, CB10 1DR
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 30 Oct 2025 · next due 13 Nov 2026
Current officers · 3
- Pramex International Ltd — corporate secretary, appointed 16 Dec 2025
- Martin Dubuc — director, appointed 1 Sept 2025
- Alexander Kurze — director, appointed 28 Nov 2025
Source: Companies House public register · retrieved 16 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does Congenica do?
- Congenica provides genomic variant analysis and interpretation software for clinical diagnostic laboratories. The platform enables rapid identification and prioritization of clinically relevant genetic variants from sequencing data, with applications in cancer mutation detection, germline variant analysis, and pathogen identification.
- Who are Congenica's investors?
- Congenica's investors include Cambridge Innovation Capital, Future Planet Capital, QVentures, Xeraya Capital, Amadeus Capital Partners, IDO Investments, Legal & General, Parkwalk Advisors and 1 more.
- How much funding has Congenica raised?
- Congenica has disclosed $50M raised across 1 of its 3 known rounds.
- Where is Congenica headquartered?
- Congenica is headquartered in Cambridge, GB.